Utility of Low Dose combination of Vitamin B (Fenomin) in the management of diabetic foot ulcer at the Cape Coast Teaching Hospital, Ghana

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202507897526024

Enrollment

120

Registered

2025-07-07

Start date

2025-08-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Fenomin

Fenomin Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes patients with University of Texas Grade 1 foot ulcers attending the outpatient clinic at the CCTH and the wound clinic of the Surgical department of the CCTH.

Exclusion criteria

Exclusion criteria: 1. Patients with diabetes and foot ulcers who are too ill to be interviewed. 2. Ulcers that are not classified as University of Texas Grade 1 ulcers 3. Patients who are on other Vitamin B formulations and do not consent to washout. 4. Patients who do not give consent to be part of the study

Design outcomes

Primary

Measure	Time frame
Rate of wound healing in patients receiving Fenomin compared to the control group	—

Secondary

Measure	Time frame
Change in ulcer size, improvement in peripheral neuropathy, and ankle-brachial pressure index	—

Countries

Ghana

Contacts

Public ContactKwame ;Lilian Yeboah;Addai

PhD Candidate ;PhD Candidate

kwameyeboah@outlook.com;lilianaddai@yahoo.com+233244661187;+233206300698

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026